8 AI Drug Discovery and Manufacturing Stocks to Buy
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
According to Direxion CEO Douglas Yones, Eli Lilly and Palo Alto Networks are prime candidates for leveraged trading.
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
We are thrilled to welcome Michael to Avalo’s Board of Directors during this pivotal time in our Company’s growth,” said Dr. Garry Neil, CEO of Avalo Therapeutics. “Michael’s extensive experience in ...